PRKCE and prostate carcinoma: We also found that a continuous activation of PKCε in prostate cancer cells occurs by signaling from OXER1, a G protein-coupled receptor (GPCR) for which the 5-Lox metabolite 5-oxoETE serves as the major ligand (30).